BofA update shows where active managers are putting money
Khalifa Sammy, Chief Technology Officer at Vicarious Surgical Inc. (NYSE:RBOT), recently sold 129 shares of the company’s Class A common stock. The stock has experienced significant volatility, dropping nearly 20% in the past week despite a notable 42% gain over the last six months, according to InvestingPro data. The transaction, executed on March 21, 2025, was valued at approximately $1,028, with the shares sold at a weighted average price of $7.9707 each. This sale was conducted to cover tax withholding obligations related to the vesting of restricted stock units granted in November 2021. Following this transaction, Sammy holds 36,522 shares directly. With analyst price targets ranging from $8.50 to $13.00, and the company showing a weak financial health score according to InvestingPro’s comprehensive analysis (which includes 10+ additional key insights available to subscribers), investors should closely monitor insider activity patterns.
In other recent news, Vicarious Surgical Inc. reported its financial results for the fourth quarter of 2024, highlighting a significant reduction in operating expenses by 17% year-over-year. The company posted an adjusted loss per share of $2.43, which was better than the expected loss of $2.69. Despite reporting zero revenue for the quarter, the company maintained a cash balance of approximately $49 million at the end of the fiscal year. Vicarious Surgical anticipates a cash burn of about $50 million in 2025 and is exploring options to manage its financial resources effectively.
A key development for the company was the successful integration of its Version 1.0 surgical robotic system, which is seen as a positive step towards achieving its clinical goals. However, the company faced some supply chain issues that have delayed the timeline for first-in-human cases to late 2025. Piper Sandler adjusted its price target for Vicarious Surgical to $8.50 from $10.50, maintaining a Neutral rating, while BTIG also maintained a Neutral rating post-results. In corporate news, Randy Clark transitioned from his role as President to a member of the Board of Directors, where he will continue to contribute to the company’s strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.